Table 1. Clinical characteristics of enrolled individuals.
| Lung Cancer Patients Mean (range) | Healthy Volunteers Mean (range) | P | |
|---|---|---|---|
| Number of individuals | 57 | 56 | - |
| Sex (M:F) | 31:26 | 26:30 | 0.3976 |
| Age | 66.72 (44–84) | 47.52 (22–92) | 0.0001 |
| Pack-years | 43.12 (0–165) | 10.42 (0–72) | 0.0001 |
| History of thrombosis | 18 | 2 | 0.0001 |
| Type of cancer | |||
| Adenocarcinoma | 35 | - | |
| Squamous cell | 8 | - | |
| Other | 14 | - | |
| % CD4+ cells | 0.57% (0.0008% - 5.38%) | 0.47% (0.0008% - 4.36%) | 0.3238 |
| % CD8+ cells | 0.36% (0.0002% - 2.09%) | 0.54% (0.03% - 7.71%) | 0.2040 |
| % Platelets | 14.2% (2.26% - 47.97%) | 15.4% (0.20% - 51.68%) | 0.6141 |
| % Activated Platelets | 6.85% (0.30% - 20.38%) | 3.81% (0.26% - 54.08%) | 0.0565 |
| CD42b expression (MFI) | 200.9 (78.4–1078) | 239.0 (84.3–1029) | 0.6513 |
| CD62P expression (MFI) | 29.12 (3.76–508) | 11.69 (2.37–314) | 0.0005 |